Enhanced features, launched at the HIMSS 23 Conference, incorporates point of care functionality alongside extensive reference content Chicago, Illinois--(Newsfile Corp. - April 18, 2023) - Elsevier, ...
Drug Class Overviews revamped to address the changing needs of health care professionals Leading drug information provider Elsevier / Gold Standard announced today its new Drug Class Overviews, making ...
LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital ...
London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, ...
Elsevier, a leading provider of medical information products and services, has improved its comprehensive drug reference tool Clinical Pharmacology by powering the service with the company’s search ...
Enriching and providing unprecedented levels of access to content can drive smarter healthcare applications, improve data delivery, increase efficiency and enhance patient care quality Philadelphia, ...
Elsevier, a global leader in research publishing and information analytics has named Josh Schoeller to serve as president of its clinical solutions business unit, which serves healthcare professionals ...
Allscripts announced that it would incorporate Elsevier Clinical Solutions’ CPM Framework into its EHR platform. Chicago-based Allscripts leads one of three teams bidding for the Department of Defense ...
InferMed's decision support technology will augment Elsevier's evidence-based clinical solutions suite Elsevier, a world-leading provider of scientific, technical and medical information products and ...
Data from studies conducted in more than 200 countries supports greater access to research and facilitates systematic reviews, clinical trial design, medical device approvals and improved drug safety ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results